Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - NYSE:IMAX - CA45245E1097 - Common Stock

35.4 USD
-1.04 (-2.85%)
Last: 11/20/2025, 8:04:00 PM
35.4 USD
0 (0%)
After Hours: 11/20/2025, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to IMAX. IMAX was compared to 79 industry peers in the Entertainment industry. While IMAX has a great health rating, its profitability is only average at the moment. IMAX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
IMAX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

IMAX's Return On Assets of 4.45% is fine compared to the rest of the industry. IMAX outperforms 78.48% of its industry peers.
IMAX has a Return On Equity of 11.31%. This is in the better half of the industry: IMAX outperforms 79.75% of its industry peers.
With a decent Return On Invested Capital value of 7.73%, IMAX is doing good in the industry, outperforming 79.75% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IMAX is significantly below the industry average of 9.82%.
The last Return On Invested Capital (7.73%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 10.47%, IMAX belongs to the top of the industry, outperforming 83.54% of the companies in the same industry.
In the last couple of years the Profit Margin of IMAX has declined.
The Operating Margin of IMAX (19.91%) is better than 91.14% of its industry peers.
IMAX's Operating Margin has declined in the last couple of years.
IMAX has a better Gross Margin (58.89%) than 67.09% of its industry peers.
In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

7

2. Health

2.1 Basic Checks

IMAX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for IMAX has been reduced compared to 1 year ago.
IMAX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IMAX is higher compared to a year ago.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 2.74. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.74, IMAX is doing good in the industry, outperforming 72.15% of the companies in the same industry.
IMAX has a debt to FCF ratio of 2.85. This is a good value and a sign of high solvency as IMAX would need 2.85 years to pay back of all of its debts.
IMAX has a Debt to FCF ratio of 2.85. This is in the better half of the industry: IMAX outperforms 77.22% of its industry peers.
IMAX has a Debt/Equity ratio of 0.74. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
IMAX's Debt to Equity ratio of 0.74 is on the low side compared to the rest of the industry. IMAX is outperformed by 62.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.74
ROIC/WACC1.08
WACC7.13%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IMAX has a Current Ratio of 2.47. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.47, IMAX belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
A Quick Ratio of 2.12 indicates that IMAX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.12, IMAX belongs to the top of the industry, outperforming 81.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.94% over the past year.
Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
Looking at the last year, IMAX shows a quite strong growth in Revenue. The Revenue has grown by 9.30% in the last year.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%

3.2 Future

The Earnings Per Share is expected to grow by 20.13% on average over the next years. This is a very strong growth
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y43.78%
EPS Next 2Y28.33%
EPS Next 3Y19.57%
EPS Next 5Y20.13%
Revenue Next Year11.85%
Revenue Next 2Y8.98%
Revenue Next 3Y7.56%
Revenue Next 5Y6.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.33, which means the current valuation is very expensive for IMAX.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than 75.95% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.07, IMAX is valued a bit more expensive.
With a Price/Forward Earnings ratio of 22.63, IMAX is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 73.42% of the companies listed in the same industry.
IMAX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.33
Fwd PE 22.63
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.82% of the companies in the same industry are more expensive than IMAX, based on the Enterprise Value to EBITDA ratio.
79.75% of the companies in the same industry are more expensive than IMAX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.09
EV/EBITDA 15.29
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMAX may justify a higher PE ratio.
A more expensive valuation may be justified as IMAX's earnings are expected to grow with 19.57% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y28.33%
EPS Next 3Y19.57%

0

5. Dividend

5.1 Amount

No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (11/20/2025, 8:04:00 PM)

After market: 35.4 0 (0%)

35.4

-1.04 (-2.85%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)02-17 2026-02-17
Inst Owners90.65%
Inst Owner Change2.63%
Ins Owners19.38%
Ins Owner Change-1.18%
Market Cap1.90B
Revenue(TTM)377.68M
Net Income(TTM)39.55M
Analysts80
Price Target38.42 (8.53%)
Short Float %13.88%
Short Ratio5.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)8.75%
PT rev (3m)12.29%
EPS NQ rev (1m)-8.19%
EPS NQ rev (3m)-9.48%
EPS NY rev (1m)8.13%
EPS NY rev (3m)17.14%
Revenue NQ rev (1m)-2.58%
Revenue NQ rev (3m)-4.72%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 31.33
Fwd PE 22.63
P/S 5.04
P/FCF 21.09
P/OCF 17.44
P/B 5.45
P/tB 7.58
EV/EBITDA 15.29
EPS(TTM)1.13
EY3.19%
EPS(NY)1.56
Fwd EY4.42%
FCF(TTM)1.68
FCFY4.74%
OCF(TTM)2.03
OCFY5.73%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.72
PEG (5Y)N/A
Graham Number12.85
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.74
F-Score8
WACC7.13%
ROIC/WACC1.08
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
EPS Next Y43.78%
EPS Next 2Y28.33%
EPS Next 3Y19.57%
EPS Next 5Y20.13%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%
Revenue Next Year11.85%
Revenue Next 2Y8.98%
Revenue Next 3Y7.56%
Revenue Next 5Y6.43%
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year247.81%
EBIT Next 3Y56.91%
EBIT Next 5Y34.08%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

What is the fundamental rating for IMAX stock?

ChartMill assigns a fundamental rating of 6 / 10 to IMAX.


What is the valuation status for IMAX stock?

ChartMill assigns a valuation rating of 5 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 6 / 10.


What is the valuation of IMAX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IMAX CORP (IMAX) is 31.33 and the Price/Book (PB) ratio is 5.45.


What is the expected EPS growth for IMAX CORP (IMAX) stock?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 43.78% in the next year.